04.10.2014 Views

Competition in the Irish Private Health Insurance Market

Competition in the Irish Private Health Insurance Market

Competition in the Irish Private Health Insurance Market

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

EXECUTIVE SUMMARY AND RECOMMENDATIONS<br />

E 1.<br />

E 2.<br />

The <strong>Irish</strong> private health <strong>in</strong>surance market is community rated. The<br />

community rat<strong>in</strong>g system is supported by regulations concern<strong>in</strong>g<br />

lifetime cover, open enrolment, m<strong>in</strong>imum benefit and risk<br />

equalisation. These regulations are necessary for <strong>the</strong> ma<strong>in</strong>tenance of<br />

a community rated market. While <strong>the</strong>se regulations also impact on<br />

competition, <strong>the</strong> impact is fair and proportionate and <strong>the</strong> regulations<br />

facilitate competition between <strong>in</strong>surers. Never<strong>the</strong>less, <strong>the</strong> <strong>Irish</strong><br />

market is highly concentrated and <strong>the</strong>re are a number of measures<br />

recommended <strong>in</strong> this report that should be taken <strong>in</strong> order to benefit<br />

consumers by encourag<strong>in</strong>g greater competition <strong>in</strong> <strong>the</strong> market.<br />

The M<strong>in</strong>ister for <strong>Health</strong> and Children requested <strong>the</strong> <strong>Health</strong> <strong>Insurance</strong><br />

Authority (<strong>the</strong> Authority) and <strong>the</strong> <strong>Competition</strong> Authority to report<br />

jo<strong>in</strong>tly on fur<strong>the</strong>r measures to encourage competition <strong>in</strong> <strong>the</strong> private<br />

health <strong>in</strong>surance (PHI) market. Terms of Reference were agreed <strong>in</strong><br />

March 2006 and a public consultation process was conducted <strong>in</strong> April.<br />

Work on <strong>the</strong> jo<strong>in</strong>t study was <strong>in</strong> its f<strong>in</strong>al stages when <strong>the</strong> <strong>Competition</strong><br />

Authority notified <strong>the</strong> <strong>Health</strong> <strong>Insurance</strong> Authority on 18th December<br />

2006 that it did not propose to submit a report jo<strong>in</strong>tly with <strong>the</strong> <strong>Health</strong><br />

<strong>Insurance</strong> Authority but <strong>in</strong>stead <strong>in</strong>tended to submit a separate report<br />

to <strong>the</strong> M<strong>in</strong>ister. As a result <strong>the</strong> Authority has completed a report on its<br />

own based on <strong>the</strong> Terms of Reference drafted <strong>in</strong> accordance with <strong>the</strong><br />

M<strong>in</strong>ister’s request. The recommendations of <strong>the</strong> Authority are set out<br />

below.<br />

<strong>Market</strong> Description and Def<strong>in</strong>ition<br />

E 3.<br />

E 4.<br />

Chapter 2 describes <strong>the</strong> <strong>Irish</strong> private health <strong>in</strong>surance market. The<br />

take-up of private health <strong>in</strong>surance (PHI) has grown steadily over <strong>the</strong><br />

years and <strong>the</strong> coverage of PHI has now reached 51% of <strong>the</strong><br />

population (48% for <strong>the</strong> three open enrolment <strong>in</strong>surers). By<br />

<strong>in</strong>ternational standards, this is a high proportion for voluntary health<br />

<strong>in</strong>surance. Economic research has shown that <strong>the</strong> important<br />

determ<strong>in</strong>ants of demand for private health <strong>in</strong>surance <strong>in</strong> Ireland are<br />

<strong>the</strong> existence of wait<strong>in</strong>g lists for elective treatment <strong>in</strong> <strong>the</strong> public<br />

hospital system and perceptions among <strong>the</strong> public of better care be<strong>in</strong>g<br />

available for private patients, <strong>the</strong> long established nature of voluntary<br />

health <strong>in</strong>surance <strong>in</strong> Ireland, and <strong>the</strong> community rated nature of <strong>the</strong><br />

market. Growth <strong>in</strong> real <strong>in</strong>comes may also have been a significant<br />

driver of demand. This factor is additional to <strong>the</strong> rapid growth <strong>in</strong> <strong>the</strong><br />

labour force and <strong>the</strong> population <strong>in</strong> <strong>the</strong> last ten years, which has<br />

resulted <strong>in</strong> correspond<strong>in</strong>g growth <strong>in</strong> <strong>the</strong> demand for health <strong>in</strong>surance.<br />

In <strong>the</strong> absence of risk equalisation payments, <strong>in</strong>surers with younger<br />

age profiles have a significant regulatory advantage over <strong>in</strong>surers with<br />

older age profiles. This advantage has facilitated BUPA Ireland and<br />

VIVAS <strong>Health</strong> <strong>in</strong> charg<strong>in</strong>g significantly lower premiums than Vhi<br />

<strong>Health</strong>care. S<strong>in</strong>ce competition was first <strong>in</strong>troduced <strong>in</strong> 1997, <strong>the</strong><br />

market share of Vhi <strong>Health</strong>care has decl<strong>in</strong>ed steadily and as at<br />

September, 2006 was 75%. (BUPA Ireland had 22% and VIVAS<br />

<strong>Health</strong> 3%). Vhi <strong>Health</strong>care’s market share has decl<strong>in</strong>ed at a rate of<br />

around 2.5 percentage po<strong>in</strong>ts per annum.<br />

6

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!